Rare and Orphan Diseases

joint efforts will form best practices for non-profit health organizations to leverage patient self-reporting with the goal of advancing science, treatment and quality of life.

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Gil Bashe, Medika Life Editor - August 12, 2024

“Go to India” May Be a Key Market for Pharma Company Growth and Global Public Health

Looking for Zebras: Listening to Patients, Healing the Health System

Gil Bashe, Medika Life Editor - November 24, 2024

When the health ecosystem discounts patient experience, it fails individuals and incurs added costs. Delayed diagnoses lead to prolonged suffering, reduced quality of life, and higher medical expenses.

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

Gil Bashe, Medika Life Editor - July 30, 2025

Craig Martin is a strategic chameleon in health innovation. He is equally at home in boardrooms, nonprofit leadership, consulting and advisory roles, all with...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

Real-World Evidence Unlocks Consumer Voice to Improve Care

2024 Health Trends: Progress, Challenges, and Opportunities

LATEST

TRENDING

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Rare – Always Present and Never Forgotten

The Disorder That Makes Monster Faces Out of Everyone You See

Looking for Zebras: Listening to Patients, Healing the Health System

2024 Health Trends: Progress, Challenges, and Opportunities

Real-World Evidence Unlocks Consumer Voice to Improve Care

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Hair Loss: The Hidden Toll of Stress

It’s Time to Reconsider Deadly Munchausen’s Syndrome by Proxy

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

EDITORS CHOICE

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Looking for Zebras: Listening to Patients, Healing the Health System

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories